Rhythm Biosciences Limited (RHY:ASX)

$1.13

right-arrow Created with Sketch. -0.02 (-1.75%)
MCAP $239.0M
Last trade 16.10pm 17/09/2021 20mins delayed

Latest Announcements

14/09/2021 Price SensitivePSRHYRhythm Biosciences Limited
13/09/2021RHYRhythm Biosciences Limited
147
MCap
13/09/2021RHYRhythm Biosciences Limited
13/09/2021RHYRhythm Biosciences Limited
09/09/2021RHYRhythm Biosciences Limited
09/09/2021RHYRhythm Biosciences Limited
09/09/2021RHYRhythm Biosciences Limited
07/09/2021RHYRhythm Biosciences Limited

Company Overview

Rhythm Biosciences Limited is a medical diagnostics technology company. The Company is engaged in developing and commercializing Australian medical diagnostics technology for sale in domestic and international markets. The Company’s development stage product, ColoSTAT focuses to provide early detection test for colorectal cancer. The Company’s ColoSTAT blood test is used to detect colorectal cancer at all stages, including the early ones. The Company's subsidiary includes Vision Tech Bio Pty Ltd.

RHY in the news

Healthcare stock Rhythm Biosciences (RHY) successfully completes its rights issue and raises…
Rhythm Biosciences (RHY) establishes an American entity, IchorDX, to drive its expansion…
Rhythm Biosciences (RHY) confirms that part of Sonic Healthcare’s (SHL) primary medical…

Search Previous Announcements